|
|
Alphatec Holdings Inc (NASDAQ: ATEC) |
|
Price: $9.4500
$0.12 
1.286%
|
| Day's High:
| $9.510000228881836
| Week Perf:
| 0.85 %
|
| Day's Low: |
$ 9.08 |
30 Day Perf: |
2.61 % |
| Volume (M): |
1,495,165 |
52 Wk High: |
$ 23.29 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$13.28 |
| Open: |
$9.22 |
52 Wk Low: |
$6.82 |
|
|
| Market Capitalization (Millions $) |
1,480 |
| Shares
Outstanding (Millions) |
157 |
| Employees |
913 |
| Revenues (TTM) (Millions $) |
815 |
| Net Income (TTM) (Millions $) |
-110 |
| Cash Flow (TTM) (Millions $) |
-17 |
| Capital Exp. (TTM) (Millions $) |
62 |
Business Description
Alphatec Holdings Inc is a medical technology company that specializes in the design, development, and marketing of surgical solutions for the treatment of spinal disorders. The company aims to improve the quality of life for patients suffering from debilitating spinal conditions through the development of innovative medical devices and surgical techniques.
Founded in 1990, Alphatec Holdings Inc is headquartered in Carlsbad, California, and operates in over 70 countries across the world. The company has a team of over 500 employees, including engineers, surgeons, and sales professionals, who work together to develop and market the companyes products.
Alphatec Holdings Inces product portfolio includes a range of spinal implant systems, such as anterior cervical plates, cervical interbody devices, lumbar interbody devices, lateral access systems, and posterior fixation systems. These products are designed to provide surgeons with innovative and reliable solutions to address a wide range of spinal pathologies, including degenerative disc disease, herniated discs, spinal stenosis, and scoliosis.
The companyes approach to product development is focused on bringing together the latest advancements in implant technology and surgical techniques to create products that are safe, effective, and easy to use. In addition, the company maintains a strong commitment to clinical research and collaboration with leading spine surgeons to ensure that its products meet the highest standards of safety and efficacy.
Alphatec Holdings Inc has a strong track record of growth and innovation in the spinal implant market, with a number of recent product launches, successful clinical trials, and strategic partnerships. The companyes products are used by leading spine surgeons around the world, and it is considered a leading player in the global spinal implant market.
Company Address: 1950 Camino Vida Roble Carlsbad 92008 CA
Company Phone Number: 431-9286 Stock Exchange / Ticker: NASDAQ ATEC
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Stocks on the Move
Published Mon, Aug 5 2024 3:48 PM UTC
In recent weeks, Alphatec Holdings Inc. (NASDAQ: ATEC) has experienced significant turbulence in the financial markets, drawing the attention of analysts and investors alike. The backdrop of this volatility is underscored by fluctuating stock performance, earnings reports, and a range of analyst ratings that present a mixed outlook for the company.Most notably, Alphatec s sh...
|
| Business Update
Published Wed, Jul 24 2024 1:47 PM UTC
ATEC revolutionizes spine surgery with the launch of EOS Insight™, an innovative platform integrating EOS Imaging and AI technology.CARLSBAD, Calif. - Alphatec Holdings, Inc. (Nasdaq: ATEC), a leading provider of groundbreaking solutions in spine surgery, has made a significant leap towards transforming the approach to spinal procedures with the launch of its cutting-edge ...
|
| Stock Transactions
Published Fri, Oct 27 2023 8:05 PM UTC
ATEC Announces Successful Closing of Public Stock Offering, Garnering $150 Million in Gross Proceeds
CARLSBAD, Calif. - Alphatec Holdings, Inc. (ATEC) (NASDAQ: ATEC), a leading provider of innovative solutions in spine surgery, proudly revealed today the completion of its highly anticipated underwritten public offering. A total of 14,300,000 shares of ATEC s common ...
|
| Stock Transactions
Published Wed, Oct 25 2023 2:59 AM UTC
ATEC Announces Pricing of Public Offering of Common Stock, Reflecting Investor Confidence in Innovative Solutions
CARLSBAD, Calif. - Alphatec Holdings, Inc. (ATEC) (NASDAQ: ATEC), a leading provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, made a significant announcement today. The firm has successfully priced an underwritten pu...
|
| Stock Transactions
Published Tue, Oct 24 2023 8:01 PM UTC
Carlsbad-based medical technology company, Alphatec Holdings, Inc. (NASDAQ: ATEC), has recently announced an underwritten public offering aimed at raising approximately $150 million to further advance their pioneering solutions in the field of spine surgery. Dedicated to revolutionizing traditional approaches to spinal procedures, Alphatec is poised to unleash grou...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-0.71 $ |
| Revenues (TTM) |
5.2 $
|
| Cash Flow (TTM) |
- |
| Cash |
0.76 $
|
| Book Value |
-
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
892,421 |
| Net
Income per Employee (TTM) |
-120,475 |
| Receivable Turnover Ratio (TTM) |
7.94 |
| Inventory Turnover Ratio (TTM) |
1.32 |
| Asset Turnover Ratio (TTM) |
0.97 |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.71 $
|
| Revenues (TTM) |
5.2 $ |
| Cash Flow (TTM) |
- |
| Cash |
0.76 $
|
| Book Value |
- |
| Dividend (TTM) |
0 $ |
|
|
| |
| Products and Services |
|
 189.97 % |
of total Revenue |
| US |
|
178.69 % |
of total Revenue |
| Non Us |
|
11.29 % |
of total Revenue |
| |
On January 13 2025 the Alphatec Holdings Inc provided following guidance
nnAlphatec Holdings, Inc. Provides Preliminary Financial Results for 2024 and Insights for 2025 Outlooknn
CARLSBAD, Calif. – Alphatec Holdings, Inc. (Nasdaq: ATEC), a pioneering company committed to transforming spine surgery through innovative solutions, has released its preliminary financial results for both the fourth quarter and entire fiscal year ending December 31, 2024. In addition, the company has offered its financial outlook for the upcoming year, 2025.
While specific figures related to full-year 2025 revenue and other financial metrics have not been disclosed, the company’s guidance indicates a positive trajectory.
nnPreliminary Financial Results for 2024:nn
|
|
|
3.22%